Correlation Between Coya Therapeutics, and PolyPid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and PolyPid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and PolyPid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and PolyPid, you can compare the effects of market volatilities on Coya Therapeutics, and PolyPid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of PolyPid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and PolyPid.

Diversification Opportunities for Coya Therapeutics, and PolyPid

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Coya and PolyPid is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and PolyPid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PolyPid and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with PolyPid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PolyPid has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and PolyPid go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and PolyPid

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the PolyPid. In addition to that, Coya Therapeutics, is 2.24 times more volatile than PolyPid. It trades about -0.25 of its total potential returns per unit of risk. PolyPid is currently generating about 0.05 per unit of volatility. If you would invest  342.00  in PolyPid on August 29, 2024 and sell it today you would earn a total of  9.00  from holding PolyPid or generate 2.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Coya Therapeutics, Common  vs.  PolyPid

 Performance 
       Timeline  
Coya Therapeutics, Common 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, sustained solid returns over the last few months and may actually be approaching a breakup point.
PolyPid 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PolyPid has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, PolyPid is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Coya Therapeutics, and PolyPid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coya Therapeutics, and PolyPid

The main advantage of trading using opposite Coya Therapeutics, and PolyPid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, PolyPid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPid will offset losses from the drop in PolyPid's long position.
The idea behind Coya Therapeutics, Common and PolyPid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.